2024 Global Health Equity Challenge
SAANS
Advanced infrastructure-independent neonatal respiratory support system which universalizes access to non-invasive breathing support for the neonatal and pediatrics.
Solution Pitch
The Problem
Over one million newborns die annually within 28 days due to inadequate breathing support. Timely interventions like CPAP and HFNC could reduce mortality by up to 50%, but current systems rely on compressed oxygen, electricity, and specialized equipment—limiting access in low-resource settings where these tools are most needed.
The Solution
Saans is an infrastructure-independent, low-skill device that delivers gold-standard respiratory support to newborns and pediatric patients, typically available only in NICUs with sophisticated infrastructure.
Features:
- Multi-therapy flexibility: Saans provides multiple therapies in a single device, offering caregivers the flexibility to optimize care while minimizing investment in additional equipment.
- Infrastructure independence: With a built-in air source, six hours of battery backup, and the capability to work with oxygen concentrators, cylinders, and piped oxygen, Saans reduces dependence on existing infrastructure.
- User-friendly monitoring: It features a digital, dynamic display for monitoring key parameters like Flow, FiO2, and Pressure, with inbuilt alarms to reduce caregiver dependency and lower training and skill requirements.
- Advanced connectivity: The system supports remote data sharing and potentially an AI-based clinical decision support system.
These features make the Saans system an essential tool for enabling caregivers to deliver gold-standard therapy to every newborn in need.
Stats
An estimated 100,000 patients have been treated with SAANS' devices
Organization Type:
For-profit, including B-Corp or similar models
Headquarters:
Bengaluru, India
Stage:
Growth
Working In:
India
Current Full-Time Employees:
42
Website:
https://innaccel.com/products/saans/
to Top